# The Effects of L-arabinose on Intestinal Sucrase Activity in Man

> **NCT00302302** · PHASE1 · COMPLETED · sponsor: **University of Copenhagen** · enrollment: 15 (actual)

## Conditions studied

- Blood Glucose

## Interventions

- **DRUG:** L-arabinose

## Key facts

- **NCT ID:** NCT00302302
- **Lead sponsor:** University of Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2005-11
- **Final completion:** 2006-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2014-02-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00302302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00302302, "The Effects of L-arabinose on Intestinal Sucrase Activity in Man". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00302302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*